These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15036405)

  • 21. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.
    Anderson GL; Kooperberg C; Geller N; Rossouw JE; Pettinger M; Prentice RL
    Clin Trials; 2007; 4(3):207-17. PubMed ID: 17715246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A practical limit to trials needed in one-person randomized controlled experiments.
    Alemi R; Alemi F
    Qual Manag Health Care; 2007; 16(2):130-4. PubMed ID: 17426611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The fallacy of enrolling only high-risk subjects in cancer prevention trials: is there a "free lunch"?
    Baker SG; Kramer BS; Corle D
    BMC Med Res Methodol; 2004 Oct; 4():24. PubMed ID: 15461821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Statistical notes. Absolute and relative effect measures].
    Marubini E; Reina G
    Ital Heart J Suppl; 2004 Jun; 5(6):466-71. PubMed ID: 15471151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations.
    Bradbury BD; Brookhart MA; Winkelmayer WC; Critchlow CW; Kilpatrick RD; Joffe MM; Feldman HI; Acquavella JF; Wang O; Rothman KJ
    Am J Kidney Dis; 2009 Sep; 54(3):554-60. PubMed ID: 19592144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.
    O'Malley AJ; Normand SL
    Biometrics; 2005 Jun; 61(2):325-34. PubMed ID: 16011678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of clinical data with breached blindness.
    Chow SC; Shao J
    Stat Med; 2004 Apr; 23(8):1185-93. PubMed ID: 15083477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strength of accumulating evidence and data monitoring committee decision making.
    George SL; Freidlin B; Korn EL
    Stat Med; 2004 Sep; 23(17):2659-72. PubMed ID: 15316949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial--Recent developments in capture-recapture methods and their applications.
    Böhning D
    Biom J; 2008 Dec; 50(6):954-6. PubMed ID: 19035557
    [No Abstract]   [Full Text] [Related]  

  • 31. The importance of varying the event generation process in simulation studies of statistical methods for recurrent events.
    Metcalfe C; Thompson SG
    Stat Med; 2006 Jan; 25(1):165-79. PubMed ID: 16217859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of methods to analyse continuous data from pseudo cluster randomized trials.
    Teerenstra S; Moerbeek M; Melis RJ; Borm GF
    Stat Med; 2007 Sep; 26(22):4100-15. PubMed ID: 17328006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is significant relevant? Validity and patient benefit of randomized controlled clinical trials on age-related macular degeneration.
    Joussen AM; Lehmacher W; Hilgers RD; Kirchhof B
    Surv Ophthalmol; 2007; 52(3):266-78. PubMed ID: 17472802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample size and the probability of a successful trial.
    Chuang-Stein C
    Pharm Stat; 2006; 5(4):305-9. PubMed ID: 17128428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical methods for active extension trials.
    Hu Z; Follmann D
    Stat Med; 2007 May; 26(12):2433-48. PubMed ID: 17066400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving the efficiency of estimation in randomized trials of adaptive treatment strategies.
    Lavori PW; Dawson R
    Clin Trials; 2007; 4(4):297-308. PubMed ID: 17848491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancing the validity and utility of randomized clinical trials in addictions treatment research: III. Data processing and statistical analysis.
    Del Boca FK; Darkes J
    Addiction; 2007 Sep; 102(9):1356-64. PubMed ID: 17511751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graphical methods to summarize data.
    Indrayan A; Satyanarayana L
    Indian Pediatr; 2000 Jan; 37(1):55-62. PubMed ID: 10745389
    [No Abstract]   [Full Text] [Related]  

  • 39. Intracluster correlation coefficients in cluster randomized trials: empirical insights into how should they be reported.
    Campbell MK; Grimshaw JM; Elbourne DR
    BMC Med Res Methodol; 2004 Apr; 4():9. PubMed ID: 15115554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From innumeracy to insight: the uncertainty of help versus harm in treatment of asymptomatic aortic aneurysms.
    Legemate DA; Bossuyt PM
    Eur J Vasc Endovasc Surg; 2006 Dec; 32(6):620-3. PubMed ID: 16931067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.